These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8996206)

  • 21. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
    See RE
    Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity.
    Aguiar LM; Macedo DS; de Freitas RM; de Albuquerque Oliveira A; Vasconcelos SM; de Sousa FC; de Barros Viana GS
    Life Sci; 2005 Mar; 76(19):2193-202. PubMed ID: 15733934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.
    Gong L; Kostrzewa RM; Perry KW; Fuller RW
    Brain Res Dev Brain Res; 1993 Dec; 76(2):233-8. PubMed ID: 8149589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
    Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.
    Delfino MA; Stefano AV; Ferrario JE; Taravini IR; Murer MG; Gershanik OS
    Behav Brain Res; 2004 Jul; 152(2):297-306. PubMed ID: 15196797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifelong Rodent Model of Tardive Dyskinesia-Persistence After Antipsychotic Drug Withdrawal.
    Kostrzewa RM; Brus R
    Curr Top Behav Neurosci; 2016; 29():353-362. PubMed ID: 26472552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation.
    Dewar KM; Paquet M; Reader TA
    Neurochem Int; 1997 Jun; 30(6):613-21. PubMed ID: 9153003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
    Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Kamdar DP; Walker PD
    Synapse; 2003 Nov; 50(2):164-70. PubMed ID: 12923819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance between striatal expression of Fos, proenkephalin mRNA, prodynorphin mRNA and rotation induced by l-stepholidine in 6-hydroxydopamine-lesioned rats.
    Ding YM; Tang FM; Yu LP; Fu Y; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Oct; 21(10):885-92. PubMed ID: 11501038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
    Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
    Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
    Schröder U; Schröder H; Augustin W; Sabel BA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias].
    Yuan CX; Ye Q; Wang J; Zhang Y; Yuan CG
    Zhong Xi Yi Jie He Xue Bao; 2008 Oct; 6(10):1024-8. PubMed ID: 18847536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
    Narumi S; Nagawa Y
    Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrastriatal infusion of amiloride increases rotations in 6-OHDA lesioned rats and "down-regulates" D2 receptors in the striatum and 5-HT2A receptors in the cortex.
    Jamrozik Z; De Yebenes JG; Troung DD; Cadet J
    Pol J Pharmacol; 1994; 46(5):417-22. PubMed ID: 7894528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.